D. Steven Conly - 29 Oct 2026 Form 3 Insider Report for WATERS CORP /DE/ (WAT)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
06 Nov 2026, 18:59:50 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kimberly Larie, attorney-in-fact for Steven Conly
Filing notes and source

Key filing fact

D. Steven Conly filed Form 3 for WATERS CORP /DE/ (WAT) on 06 Nov 2026.

Key facts

  • This page summarizes D. Steven Conly's Form 3 filing for WATERS CORP /DE/ (WAT).
  • 0 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 06 Nov 2026, 18:59.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002108888 Primary reporting owner

Conly D Steven

Relationship
SVP, Waters Biosciences
Address
C/O WATERS CORPORATION, 34 MAPLE STREET, MILFORD
Signature
/s/ Kimberly Larie, attorney-in-fact for Steven Conly
Signature date
06 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WAT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,030
Date
29 Oct 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WAT holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,550
Exercise price
$411.85
Footnotes
F3, F4
WAT holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,513
Exercise price
$440.63
Footnotes
F3, F4
WAT holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,295
Exercise price
$464.50
Footnotes
F3, F4
WAT holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,065
Exercise price
$414.01
Footnotes
F3, F4
WAT holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,387
Exercise price
$446.07
Footnotes
F3, F4
WAT holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,966
Exercise price
$440.45
Footnotes
F3, F5
WAT holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,738
Exercise price
$441.98
Footnotes
F3, F6
WAT holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,939
Exercise price
$414.90
Footnotes
F3, F7
WAT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
574
Exercise price
$319.44
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Represents (i) 339 shares of the Issuer's common stock, (ii) 117 unvested restricted stock units ("RSUs") awarded under the Issuer's 2020 Equity Incentive Plan, and (iii) 5,574 unvested RSUs awarded under the Issuer's 2026 Equity-Based Incentive Plan in connection with the transactions set forth in that certain Agreement and Plan of Merger, dated as of July 13, 2025 (the "Merger Agreement"), by and among the Issuer, Becton, Dickinson and Company, Augusta SpinCo Corporation and Beta Merger Sub, Inc. The RSUs awarded under the 2020 Equity Incentive Plan will vest in four substantially equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Footnote F2

(Continued from footnote 1) The RSUs awarded under the 2026 Equity-Based Incentive Plan will vest as follows: 1,529 will vest on November 26, 2026; 279 will vest on March 3, 2027; 1,624 will vest on November 26, 2027; 278 will vest on March 3, 2028; and 1,864 will vest on November 26, 2028, subject to the Reporting Person's continued service with the Issuer on each such vesting date. All RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.

Footnote F3

These stock appreciation rights were awarded under the Issuer's 2026 Equity-Based Incentive Plan in connection with the transactions set forth in the Merger Agreement.

Footnote F4

These stock appreciation rights are fully vested and exercisable as of the date hereof.

Footnote F5

These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2023, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Footnote F6

These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2024, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Footnote F7

These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2025, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Footnote F8

The shares of common stock underlying this stock option vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .